CELL INTELLIGENCE · 肿瘤细胞治疗研究

下一代基于抗体的癌症治疗：抗体-药物偶联物和双特异性抗体在血液系统恶性肿瘤和实体瘤中的应用

Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors

通过红细胞介导的 mRNA 递送在体内生成 CAR 髓系细胞用于癌症免疫治疗

In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy.

CAR-T 疗法治疗中枢神经系统肿瘤的进展

Advances in CAR-T therapy for central nervous system tumors.

CAR-T 细胞：治疗脑肿瘤及其他疾病的工程化免疫细胞

CAR T cells: engineered immune cells to treat brain cancers and beyond.

半胱氨酸介导的嵌合抗原受体聚集增强 T 细胞抗肿瘤疗效

Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor.

2009 至 2021 年 CAR-T 细胞的文献计量学与知识图谱分析

A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021.

作为一种具有巨大潜力和临床应用前景的抗肿瘤疗法，CAR-T 细胞疗法仍处于快速发展阶段。CAR-T 细胞相关领域在未来仍将是研究热点。

具有 dectin-1 胞内信号结构域的 CAR-T 细胞的独特功能

Distinct functions of CAR-T cells possessing a dectin-1 intracellular signaling domain.

利用位点特异性偶联系统构建用于 CAR-T 细胞治疗的开关模块

Construction of Switch Modules for CAR-T Cell Treatment Using a Site-Specific Conjugation System.

结直肠癌和浸润性乳腺癌中 CAR-T 细胞治疗的临床新视角与挑战

Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer.

胰岛素样生长因子 2 受体是三阴性乳腺癌患者预后不良相关的关键免疫相关基因：一项生物信息学分析

Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast ca

IGF2R 可作为 TNBC 患者预后不良的指标，并可作为未来 TNBC 免疫治疗的潜在靶点和研究方向。